Edwards Lifesciences (EW): THV Is The Key, Raising PT - Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Edwards Lifesciences (EW) PT Raised to $140 at Canaccord Genuity
July 27, 2016 10:15 AM EDTCanaccord Genuity analyst Jason Mills reiterated a Buy rating and raised his price target on Edwards Lifesciences (NYSE: EW) to $140.00 (from $132.00) following the latest 'beat and raise'.
Mills commented, ""We view EW as one of the most attractive large-cap growth ideas in... More
Edwards Lifesciences (EW) PT Raised to $139 at UBS Amid Strong Q2
July 27, 2016 8:14 AM EDTUBS analyst Matt Miksic reiterated a Buy rating and boosted his price target on Edwards Lifesciences (NYSE: EW) to $139.00 (from $135.00) following strong results after the close.
Miksic commented, "Our intra-quarter checks indicated strong volume growth, contrary to Street concerns over third-party data indicating otherwise. However, EW delivered results... More
BofA/Merrill Lynch Upgrades Edwards Lifesciences (EW) to Buy
July 27, 2016 7:30 AM EDTBofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $108.35 yesterday.
... More


